1. "Center for Pancreatic Cancer Research"
Formats
  1. Journal Article (4995)
  2. Meeting Abstract (2462)
  3. Book Section (214)
  4. Review (209)
  5. Editorial (129)
  6. Conference Paper (75)
  7. Correspondence (46)
  8. Research Letter (40)
  9. Miscellaneous (39)
  10. Guidelines (37)
  11. Book Whole (19)
Groups
  1. Center for Pancreatic Cancer Research (8265)
  2. Department of Medicine (3883)
  3. Solid Tumor Oncology Division (3194)
  4. Surgery (3116)
  5. GSK Faculty (2869)
  6. Epidemiology and Biostatistics (2495)

More Groups

People
  1. Mithat Gonen (1028)
  2. William Jarnagin (903)
  3. Eileen O'Reilly (780)
  4. Michael D'Angelica (777)
  5. T Peter Kingham (609)
  6. David Kelsen (537)

More People

Years
  1. 2025 (185)
  2. 2024 (487)
  3. 2023 (522)
  4. 2022 (602)
  5. 2021 (555)
  6. 2020 (555)

More Years

Publications
  1. Journal of Clinical Oncology (917)
  2. Annals of Surgical Oncology (389)
  3. Cancer Research (225)
  4. International Journal of Radiation Oncology, Biology, Physics (219)
  5. Laboratory Investigation (206)
  6. Modern Pathology (191)

More Publications

Publishers
  1. American Society of Clinical Oncology (986)
  2. Springer (831)
  3. Elsevier Inc. (810)
  4. Nature Publishing Group (623)
  5. American Association for Cancer Research (546)
  6. Elsevier Science, Inc. (504)

More Publishers

Results (8265)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
    Journal Article

    McIntyre, C. A.; Grimont, A.; Park, J.; Meng, Y.; Sisso, W. J.; Seier, K.; Jang, G. H.; Walch, H.; Aveson, V. G.; Falvo, D. J.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors
    Journal Article

    Hickman, R. A.; Miller, A. M.; Holle, B. M.; Jee, J.; Liu, S. Y.; Ross, D.; Yu, H.; Riely, G. J.; Ombres, C.; Gewirtz, A. N.; more...
    Acta Neuropathologica Communications (2024)

    Fulltext@MSK | Save
  • Receptor tyrosine kinase inhibition results in the regression of acral melanoma by targeting the tumor microenvironment
    Meeting Abstract

    Smith, E. A.; Belote, R. L.; Cruz, N. E.; Mustafa, T. E.; Becker, C.; Alizada, S.; Chan, T.; Seasor, T. A.; Balatico, M.; Cortes-Sanchez, E.; more...
    Journal of Investigative Dermatology (2024)

    Fulltext@MSK | Save
  • Inherited genetics underlying risk of multiple primary melanoma
    Meeting Abstract

    Gibbs, D. C.; Orlow, I.; Kanetsky, P.; Luo, L.; Cust, A.; Begg, C.; Berwick, M.; Thomas, N.
    Journal of Investigative Dermatology (2024)

    Fulltext@MSK | Save
  • Correlating clinical and pathological spectrums: A study of germline and somatic DICER1 alterations in cancer patients
    Meeting Abstract

    Dikoglu, E.; Mandelker, D.; Vanderbilt, C.
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Updated overall survival analysis with 29-month follow-up of NAPOLI 3
    Meeting Abstract

    Hussein, M. A.; Khan, G.; Chandana, S. R.; Cid, R. A. P.; Kiss, I.; Gallego, J.; Macarulla, T.; De la Fouchardiere, C.; Goetze, T.; Dean, A. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • NRG Oncology/RTOG 0848: Results after adjuvant chemotherapy +/- chemoradiation for patients with resected periampullary pancreatic adenocarcinoma (PA)
    Meeting Abstract

    Abrams, R. A.; Winter, K. A.; Goodman, K. A.; Regine, W.; Safran, H.; Berger, A. C.; Guha, C.; Kachnic, L. A.; Gillin, M.; Seaward, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Alliance A022106: A phase II/III trial of NABPLAGEM vs nab-paclitaxel/gemcitabine as second-line treatment for BRCA1/2 or PALB2 mutant metastatic pancreatic ductal adenocarcinoma (PLATINUM)
    Meeting Abstract

    Tsang, E. S.; Shi, Q.; Olive, K. P.; Collisson, E. A.; Dixon, J. G.; Cusnir, M.; Winograd, R.; Botta, G. P.; Wadlow, R. C.; Shergill, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer-Evaluating radiation, ablation, and surgery (ERASur)
    Meeting Abstract

    Miller, E. D.; Hitchcock, K.; Shi, Q.; Dixon, J. G.; Gholami, S.; White, S. B.; Wu, C.; Goulet, C. C.; Jee, K. W.; Wright, C. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical and translational results from REVOLUTION cohorts A (nivolumab + ipilimumab + chemotherapy) and B (hydroxychloroquine + ipilimumab + chemotherapy) in patients with previously untreated metastatic pancreatic adenocarcinoma
    Meeting Abstract

    O'Reilly, E. M.; Wainberg, Z. A.; Fisher, G. A. Jr; Wolff, R. A.; Ko, A. H.; O'Hara, M. H.; Spencer, C. N.; Yu, J. X.; Da Silva, D. M.; Padron, L. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save